Clinical connection between rheumatoid arthritis and liver damage
- 7 April 2018
- journal article
- review article
- Published by Springer Nature in Rheumatology International
- Vol. 38 (5) , 715-724
Abstract
When liver damage is present in rheumatoid arthritis (RA) patients, it is sometimes difficult to determine whether it is a hepatic manifestation of RA, associated primary liver disease or hepatotoxic liver disease which developed during the treatment of RA. Liver damage during RA is most common in the form of asymptomatic abnormal liver tests. Occasionally, liver damage may progress to cirrhosis. Patients with RA are more susceptible to an associated autoimmune liver disease. Medications used in rheumatology are often hepatotoxic and it is difficult to differentiate between hepatic manifestations of the primary disease and potential hepatotoxicity of the administered medications. The significance of the paper is in the fact that it includes the most relevant and the latest information on this commonly present problem in clinical practice. The aim of the author is to provide comprehensive but at the same time concise data which will be useful to the doctors who come into contact with RA patients with symptomatic or asymptomatic liver disease. Timely diagnosis and treatment of liver disease in RA patients can significantly influence the course and outcome of rheumatoid arthritis.Keywords
This publication has 98 references indexed in Scilit:
- Identification of Risk Factors for Elevated Transaminases in Methotrexate Users Through an Electronic Health RecordArthritis Care & Research, 2014
- Kinetic Profiles and Management of Hepatitis B Virus Reactivation in Patients With Immune‐Mediated Inflammatory DiseasesArthritis Care & Research, 2013
- Contribution of obesity to the rise in incidence of rheumatoid arthritisArthritis Care & Research, 2012
- Primary biliary cirrhosis # †Hepatology, 2009
- Diagnosis, management, and treatment of hepatitis C: An update # † ‡Hepatology, 2009
- Liver biopsy†Hepatology, 2009
- American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritisArthritis Care & Research, 2008
- Non‐alcoholic Steatohepatitis2005
- Usefulness of routine hepatitis C virus, hepatitis B virus, and parvovirus B19 serology in the diagnosis of recent-onset inflammatory arthritidesArthritis & Rheumatism, 2005
- Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factorsArchives of internal medicine (1960), 1994